215 related articles for article (PubMed ID: 37197656)
1. Interferon regulatory factor 3 mediates effective antiviral responses to human coronavirus 229E and OC43 infection.
Duncan JKS; Xu D; Licursi M; Joyce MA; Saffran HA; Liu K; Gohda J; Tyrrell DL; Kawaguchi Y; Hirasawa K
Front Immunol; 2023; 14():930086. PubMed ID: 37197656
[TBL] [Abstract][Full Text] [Related]
2. Human coronaviruses 229E and OC43 replicate and induce distinct antiviral responses in differentiated primary human bronchial epithelial cells.
Loo SL; Wark PAB; Esneau C; Nichol KS; Hsu AC; Bartlett NW
Am J Physiol Lung Cell Mol Physiol; 2020 Dec; 319(6):L926-L931. PubMed ID: 32903043
[TBL] [Abstract][Full Text] [Related]
3. Activation of STING Signaling Pathway Effectively Blocks Human Coronavirus Infection.
Liu W; Reyes HM; Yang JF; Li Y; Stewart KM; Basil MC; Lin SM; Katzen J; Morrisey EE; Weiss SR; You J
J Virol; 2021 May; 95(12):. PubMed ID: 33789998
[TBL] [Abstract][Full Text] [Related]
4. More tools for our toolkit: The application of HEL-299 cells and dsRNA-nanoparticles to study human coronaviruses in vitro.
Semple SL; Alkie TN; Jenik K; Warner BM; Tailor N; Kobasa D; DeWitte-Orr SJ
Virus Res; 2022 Nov; 321():198925. PubMed ID: 36115551
[TBL] [Abstract][Full Text] [Related]
5. Antiviral Activity of Type I, II, and III Interferons Counterbalances ACE2 Inducibility and Restricts SARS-CoV-2.
Busnadiego I; Fernbach S; Pohl MO; Karakus U; Huber M; Trkola A; Stertz S; Hale BG
mBio; 2020 Sep; 11(5):. PubMed ID: 32913009
[TBL] [Abstract][Full Text] [Related]
6. Comparative Analysis of Six IRF Family Members in Alveolar Epithelial Cell-Intrinsic Antiviral Responses.
Wüst S; Schad P; Burkart S; Binder M
Cells; 2021 Sep; 10(10):. PubMed ID: 34685580
[TBL] [Abstract][Full Text] [Related]
7. Involvement of Interferon Regulatory Factor 7 in Nicotine's Suppression of Antiviral Immune Responses.
Han H; Huang W; Du W; Shen Q; Yang Z; Li MD; Chang SL
J Neuroimmune Pharmacol; 2019 Dec; 14(4):551-564. PubMed ID: 31154625
[TBL] [Abstract][Full Text] [Related]
8. Brilacidin, a COVID-19 drug candidate, demonstrates broad-spectrum antiviral activity against human coronaviruses OC43, 229E, and NL63 through targeting both the virus and the host cell.
Hu Y; Jo H; DeGrado WF; Wang J
J Med Virol; 2022 May; 94(5):2188-2200. PubMed ID: 35080027
[TBL] [Abstract][Full Text] [Related]
9. Transcriptomic profiling and genomic mutational analysis of Human coronavirus (HCoV)-229E -infected human cells.
Friedman N; Jacob-Hirsch J; Drori Y; Eran E; Kol N; Nayshool O; Mendelson E; Rechavi G; Mandelboim M
PLoS One; 2021; 16(2):e0247128. PubMed ID: 33630927
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of coronavirus infection by a synthetic STING agonist in primary human airway system.
Zhu Q; Zhang Y; Wang L; Yao X; Wu D; Cheng J; Pan X; Liu H; Yan Z; Gao L
Antiviral Res; 2021 Mar; 187():105015. PubMed ID: 33444702
[TBL] [Abstract][Full Text] [Related]
11. Severe Acute Respiratory Syndrome Coronavirus 2 Vaccination Boosts Neutralizing Activity Against Seasonal Human Coronaviruses.
Lawrenz J; Xie Q; Zech F; Weil T; Seidel A; Krnavek D; van der Hoek L; Münch J; Müller JA; Kirchhoff F
Clin Infect Dis; 2022 Aug; 75(1):e653-e661. PubMed ID: 35079775
[TBL] [Abstract][Full Text] [Related]
12. Induction of antiviral gene expression by cyclosporine A, but not inhibition of cyclophilin A or B, contributes to its restriction of human coronavirus 229E infection in a lung epithelial cell line.
Mamatis JE; Gallardo-Flores CE; Sangwan U; Tooley TH; Walsh T; Colpitts CC
Antiviral Res; 2023 Nov; 219():105730. PubMed ID: 37805057
[TBL] [Abstract][Full Text] [Related]
13. Neutralizing and binding activities against SARS-CoV-1/2, MERS-CoV, and human coronaviruses 229E and OC43 by normal human intravenous immunoglobulin derived from healthy donors in Japan.
Kubota-Koketsu R; Terada Y; Yunoki M; Sasaki T; Nakayama EE; Kamitani W; Shioda T
Transfusion; 2021 Feb; 61(2):356-360. PubMed ID: 33104267
[TBL] [Abstract][Full Text] [Related]
14. Effect of Jinzhen granule on two coronaviruses: The novel SARS-CoV-2 and the HCoV-229E and the evidences for their mechanisms of action.
Ma Q; Wang Z; Chen R; Lei B; Liu B; Jiang H; Chen Z; Cai X; Guo X; Zhou M; Huang J; Li X; Dai J; Yang Z
Phytomedicine; 2022 Jan; 95():153874. PubMed ID: 34923232
[TBL] [Abstract][Full Text] [Related]
15. Nirmatrelvir exerts distinct antiviral potency against different human coronaviruses.
Li J; Wang Y; Solanki K; Atre R; Lavrijsen M; Pan Q; Baig MS; Li P
Antiviral Res; 2023 Mar; 211():105555. PubMed ID: 36791846
[TBL] [Abstract][Full Text] [Related]
16. Protease Inhibitors: Candidate Drugs to Inhibit Severe Acute Respiratory Syndrome Coronavirus 2 Replication.
Yamaya M; Nishimura H; Deng X; Kikuchi A; Nagatomi R
Tohoku J Exp Med; 2020 May; 251(1):27-30. PubMed ID: 32448818
[TBL] [Abstract][Full Text] [Related]
17. RIG-I is a key antiviral interferon-stimulated gene against hepatitis E virus regardless of interferon production.
Xu L; Wang W; Li Y; Zhou X; Yin Y; Wang Y; de Man RA; van der Laan LJW; Huang F; Kamar N; Peppelenbosch MP; Pan Q
Hepatology; 2017 Jun; 65(6):1823-1839. PubMed ID: 28195391
[TBL] [Abstract][Full Text] [Related]
18. Pulsed blue light inactivates two strains of human coronavirus.
Enwemeka CS; Bumah VV; Mokili JL
J Photochem Photobiol B; 2021 Sep; 222():112282. PubMed ID: 34404018
[TBL] [Abstract][Full Text] [Related]
19. Human Milk Antibodies Against S1 and S2 Subunits from SARS-CoV-2, HCoV-OC43, and HCoV-229E in Mothers with A Confirmed COVID-19 PCR, Viral SYMPTOMS, and Unexposed Mothers.
Demers-Mathieu V; DaPra C; Mathijssen G; A Sela D; M Jarvinen K; Seppo A; Fels S; Medo E
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33572480
[TBL] [Abstract][Full Text] [Related]
20. Regulation of the transcriptional activity of the IRF7 promoter by a pathway independent of interferon signaling.
Ning S; Huye LE; Pagano JS
J Biol Chem; 2005 Apr; 280(13):12262-70. PubMed ID: 15664995
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
